| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |